Announcements Trials
Browse Landscape

Status

Completed 4Withdrawn 3Terminated 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 6zanubrutinib 3tafasitamab 2obinutuzumab 2acalabrutinib 2Specimen Handling 2Rituximab 2Biopsy 2resiniferatoxin 1pirtobrutinib 1fludarabine 1duvelisib 1Therapeutics 1Sirolimus 1Prednisone 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunoglobulins 1Exercise 1Everolimus 1Disulfides 1Cyclophosphamide 1Blood Cell Count 1Biopsy, Needle 1Bendamustine Hydrochloride 1Azacitidine 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × duvelisib × Clear all
NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

Ruijin Hospital

Not yet recruiting
200 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡